NEW ORLEANS -- An investigational extravascular implantable cardioverter-defibrillator (ICD) continues to demonstrate it can appropriately shock patients and prevent sudden cardiac death, extended ...
Patients who met inclusion criteria of systolic BP ≥ 160/80 mmHg taking at least three antihypertensive medications underwent implantation of the Rheos System. Each center's Institutional Review Board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results